Payment Policy Update: Beginning September 1, 2026, Virginia Cancer Specialists will no longer accept cash. Read more here..
An antibody with potential antineoplastic activity. Specific for both the high-affinity immunoglobulin G (IgG) receptor CD64 and epidermal growth factor receptor (EGFR), bispecific antibody MDX447 may enhance cellular immune responses against EGFR positive cells, resulting in increased tumor cell lysis. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
